HepC maintains its corporate headquarters and research and development group in Budapest, Hungary and Rockville, Maryland, USA

HepC Therapeutics Inc. – Superinfection
Hungary Business Office:

Tamás Bakács, MBA
Chief Executive Officer

Miko u. 3. II. em. 11. ,1012 Budapest, HU
Tel: +36-30-688-1121

HepC Therapeutics Inc. – Superinfection
USA Business Office:

Imre Kovesdi, Ph.D.
COO & Partner

7713 Warbler, Rockville, MD, 20855, USA
Tel: +1-301-963-1641

For more information on HepC, its product candidates and licensing or partnering opportunities, please also contact: tamas@superinfectiontherapy.com